Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2019 May 17;12:3893–3903. doi: 10.2147/OTT.S199601

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2019 Yin et al.

This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).

PMC Copyright notice

Figure S1 — Curcumin reverses oxaliplatin resistance in SW480 cells. (A) MTT assay was performed to calculate the growth inhibition rate of SW480 and SW480/OXA cells treated with 0.5, 1, 2, 4, 8, 16 or 32 μM OXA for 48 hrs. (B) The growth inhibition rate of SW480/OXA cells treated with the combination of OXA and curcumin. (C) SW480/OXA cell death was detected with trypan blue staining. (D) Trypan blue positive cell rate in each group was calculated. Each experiment was repeated three times. **P<0.01 compared to control group; ^##P<0.01, compared to OXA alone group.